Page 169 - Read Online
P. 169
4. Welz, PS, Wullaert, A, Vlantis, K, Kondylis V, Fernandez-Majada V, U S A 2014;111:7391-6.
Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G, Pasparakis M. 24. Deaciuc IV, D’souza NB, de Villiers WJ, Burikhanov R, Sarphie TG,
FADD prevents RIP3-mediated epithelial cell necrosis and chronic Hill DB, McClain CJ. Inhibition of caspases in vivo protects the rat liver
intestinal inflammation. Nature 2011;477:330-4. against alcohol-induced sensitization to bacterial lipopolysaccharide.
5. Han, J, Zhong CQ, Zhang DW. Programmed necrosis: backup to Alcohol Clin Exp Res 2001;25:935-43.
and competitor with apoptosis in the immune system. Nat Immunol 25. Roca FJ, Ramakrishnan L. TNF dually mediates resistance and
2011;12:1143-9. susceptibility to mycobacteria via mitochondrial reactive oxygen
6. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular species. Cell 2013;153:521-34.
mechanisms of necroptosis: an ordered cellular explosion. Nat Rev 26. Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE.
Mol Cell Biol 2010;11:700-14. Absence of receptor interacting protein kinase 3 prevents ethanol-
7. Newton K, Sun X, Dixit VM. Kinase RIP3 is dispensable for normal induced liver injury. Hepatology 2013;57:1773-83.
NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor 27. Koshinuma S, Miyamae M, Kaneda K, Kotani J, Figueredo VM.
necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Combination of necroptosis and apoptosis inhibition enhances
Biol 2004;24:1464-9. cardioprotection against myocardial ischemia-reperfusion injury. J
8. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Anesth 2014;28:235-41.
Hakem R, Salvesen GS, Green DR. Catalytic activity of the caspase- 28. Linkermann A, Bräsen JH, Darding M, Jin MK, Sanz AB, Heller JO,
8-FLIP (L) complex inhibits RIPK3-dependent necrosis. Nature De Zen F, Weinlich R, Ortiz A, Walczak H, Weinberg JM, Green DR,
2011;471:363-7. Kunzendorf U, Krautwald S. Two independent pathways of regulated
9. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S
FK. Phosphorylation-driven assembly of the RIP1-RIP3 complex A 2013;110:12024-9.
regulates programmed necrosis and virus-induced inflammation. 29. Gao S, Andreeva K, Cooper NG. Ischemia-reperfusion injury of the
Cell 2009;137:1112-23. retina is linked to necroptosis via the ERK1/2-RIP3 pathway. Mol Vis
10. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, 2014;20:1374-87.
Vandenabeele P. Regulated necrosis: the expanding network of non- 30. Lin J, Li H, Yang M, Ren J, Huang Z, Han F, Huang J, Ma J, Zhang D,
apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014;15:135-47. Zhang Z, Wu J, Huang D, Qiao M, Jin G, Wu Q, Huang Y, Du J, Han
11. Vanlangenakker N, Vanden Berghe T, Krysko DV, Festjens N, J. A role of RIP3-mediated macrophage necrosis in atherosclerosis
Vandenabeele P. Molecular mechanisms and pathophysiology of development. Cell Rep 2013;3:200-10.
necrotic cell death. Curr Mol Med 2014;8:207-20. 31. Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W,
12. Xie T, Peng W, Yan C, Wu J, Gong X, Shi Y. Structural insights into DuHadaway JB, Goossens V, Roelandt R, Van Hauwermeiren F,
RIP3-mediated necroptotic signaling. Cell Rep 2013;5:70-8. Libert C, Declercq W, Callewaert N, Prendergast GC, Degterev A,
13. Dondelinger Y, Aguileta M, Goossens V, Dubuisson C, Grootjans Yuan J, Vandenabeele P. Necrostatin-1 analogues: critical issues
S, Dejardin E, Vandenabeele P, Bertrand MJ. RIPK3 contributes to on the specificity, activity and in vivo use in experimental disease
TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions models. Cell Death Dis 2012;3:e437.
of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ 32. Ju G, Wang J, Wang Y, Zhao X. Spinal cord contusion. Neural Regen
2013;20:1381-92.
Res 2014;9:789-94.
14. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu 33. Wang Y, Wang H, Tao Y, Zhang S, Wang J, Feng X. Necroptosis
W, Lei X, Wang X. Mixed lineage kinase domain-like protein mediates inhibitor necrostatin-1 promotes cell protection and physiological
necrosis signaling downstream of RIP3 kinase. Cell 2012;148:213-27.
15. Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu function in traumatic spinal cord injury. Neuroscience
LG, Liu ZG. Plasma membrane translocation of trimerized MLKL 2014;266:91-101.
protein is required for TNF-induced necroptosis. Nat Cell Biol 34. Wang Y, Wang J, Yang H, Zhou J, Feng X, Wang H, Tao Y.
Necrostatin-1 mitigates mitochondrial dysfunction post-spinal cord
2014;16:55-65.
16. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, Wang FS, and Wang injury. Neuroscience 2015;289:224-32.
X. Mixed lineage kinase domain-like protein MLKL causes necrotic 35. Fan H, Zhang K, Shan L, Kuang F, Chen K, Zhu K, Ma H, Ju G,
membrane disruption upon phosphorylation by RIP3. Mol Cell Wang YZ. Reactive astrocytes undergo M1 microglia/macrohpages-
2014;54:133-46. induced necroptosis in spinal cord injury. Mol Neurodegener
17. Wang Z, Jiang H, Chen S, Du F, and Wang X. The mitochondrial 2016;11:14.
phosphatase PGAM5 functions at the convergence point of multiple 36. Fan H, Tang HB, Kang J, Shan L, Song H, Zhu K, Wang J, Ju G,
necrotic death pathways. Cell 2012;148:228-43. Wang YZ. Involvement of endoplasmic reticulum stress in the
18. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, necroptosis of microglia/macrophages after spinal cord injury.
Hupe M, Cain K, MacFarlane M, Hacker G, Leverkus M. cIAPs block Neuroscience 2015;311:362-73.
Ripoptosome formation, a RIP1/caspase-8 containing intracellular 37. Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, Ye J,
cell death complex differentially regulated by cFLIP isoforms. Mol Zhang X, Chang A, Vakifahmetoglu-Norberg H, Geng J, Py B, Zhou
Cell 2011;43:449-63. W, Amin P, Berlink Lima J, Qi C, Yu Q, Trapp B, Yuan J. Activation
19. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM. of necroptosis in multiple sclerosis. Cell Rep 2015;10:1836-49.
p53 opens the mitochondrial permeability transition pore to trigger 38. Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M,
necrosis. Cell 2012;149:1536-48. Klein AD, Platt FM, Cox TM, Futerman AH. RIPK3 as a potential
20. Eigenbrod T, Park JH, Harder J, Iwakura Y, Núñez G. Cutting edge: therapeutic target for Gaucher’s disease. Nat Med 2014;20:204-8.
critical role for mesothelial cells in necrosis-induced inflammation 39. Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, Ikiz
through the recognition of IL-1 alpha released from dying cells. J B, Hoffmann L, Koolen M, Nagata T, Papadimitriou D, Nagy P,
Immunol 2008;181:8194-8. Mitsumoto H, Kariya S, Wichterle H, Henderson CE, Przedborski S.
21. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan Necroptosis drives motor neuron death in models of both sporadic
FK. Phosphorylation-driven assembly of the RIP1-RIP3 complex and familial ALS. Neuron 2014;81:1001-8.
regulates programmed necrosis and virus-induced inflammation. 40. David S, Kroner A. Repertoire of microglial and macrophage
Cell 2009;137:1112-23. responses after spinal cord injury. Nat Rev Neurosci 2011;12:388-99.
22. Clark IA. How TNF was recognized as a key mechanism of disease. 41. Humphries F, Yang S, Wang B, Moynagh PN. RIP kinases: key
Cytokine Growth Factor Rev 2007;18:335-43. decision makers in cell death and innate immunity. Cell Death Differ
23. Weng D, Marty-Roix R, Ganesan S, Proulx MK, Vladimer GI, Kaiser 2015;22:225-36.
WJ, Mocarski ES, Pouliot K, Chan FK, Kelliher MA, Harris PA, 42. Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O’Reilly L,
Bertin J, Gough PJ, Shayakhmetov DM, Goguen JD, Fitzgerald KA, Mason K, Gross O, Ma S, Guarda G, Anderton H, Castillo R, Häcker
Silverman N, Lien E. Caspase-8 and RIP kinases regulate bacteria- G, Silke J, Tschopp J. Inhibitor of apoptosis proteins limit RIP3 kinase-
induced innate immune responses and cell death. Proc Natl Acad Sci dependent interleukin-1 activation. Immunity 2012;36:215-27.
160 Neuroimmunol Neuroinflammation | Volume 3 | July 8, 2016